• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in British drugmaker

AstraZeneca To Seek US Authorization For COVID-19 Vaccine This Month Or Early Next - Sources

The number of COVID-19 cases among those who got the vaccine versus infections in participants who received a placebo will show how effective the AstraZeneca shot was at preventing illness in those age 18 and over.

Read More

AstraZeneca Forecasts 2021 Growth After Fourth-Quarter Sales Beat

The British drugmaker said it expects 2021 revenues to increase by a low teens percentage, with "faster growth" in core earnings to $4.75 to $5.00 per share.

Read More

Brazil Scrambles For India-Made Vaccines To Jumpstart Inoculations

Bharat Biotech has not yet applied for approval by Brazil's health regulator Anvisa for its Covaxin vaccine, and the agency said it would have to undergo Phase III trials in the country.

Read More

Bangladesh Signs Deal With India For 30 Million Doses Of COVID-19 Vaccine

AstraZeneca’s experimental COVID-19 vaccine is seen as one of the most advanced candidates in the race against the novel coronavirus.

Read More

GSK's Long-Acting Injection Beats Truvada In HIV Prevention Trial

Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection.

Read More